{"id":621931,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2017-05-19] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-26","captureTimestamp":"2026-02-26T01:25:19.984000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-multiple-additions-2.html","snippet":"Notice - Prescription Drug List (PDL): Multiple additions May 19, 2017 Our file number: 17-105533-859 The purpose of this Notice of Amendment is to notify the additions of atezolizumab, eliglustat and obeticholic acid to the Human and Veterinary Prescription Drug Lists (PDL).…","rawSnapshotUrl":"/api/snapshots/raw/621931","browseUrl":"https://replay.healtharchive.ca/job-6/20260226012519/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-multiple-additions-2.html#ha_snapshot=621931","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}